0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Worldwide Insulin Pump Market – Drivers, Opportunities, Trends, and Forecasts: 2017–2023
Published Date: April 2019
|
Report Code: INFO-Othe-045
Home | Category |Health |Health Conditions |Endocrine Conditions
Worldwide Insulin Pump Market Drivers Opportunities Trends and Forecasts 2017 to 2023

Worldwide Insulin Pump Market – Drivers, Opportunities, Trends, and Forecasts: 2017–2023

Code: INFO-Othe-045
Report
April 2019
92 Pages
Infoholic Research
Region: North America, South America, Europe, Middle East, Africa,
Description
Table of Content
Tables & Figures

Worldwide Insulin Pumps Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017–2023
Overview:
Insulin pump is a small and discreet device that delivers a specific amount of insulin through a needle inserted underneath the skin. The insulin pump is integrated with the receiver, transmitter, and a sensor that can be programmed to deliver constant doses of insulin during the day. It delivers and regulates blood sugar level in the body. It consists of a disposable infusion set, a cannula for subcutaneous insertion, a tubing system to connect the cannula with the insulin reservoir, and a disposable reservoir for insulin set.

Factors such as rising prevalence of diabetic patients, technological advancements, and the increasing potential in the emerging countries are expected to drive the market growth during the forecast period. The high cost of insulin pumps and stringent regulatory approval process are factors hampering the market growth.
The markets in India, Brazil, and China are also expected to grow at a rapid pace during the forecast period due to the high prevalence of diabetes in these countries.

Market Analysis:
The global insulin pumps market is estimated to witness a CAGR of 8.3% during the forecast period 2017–2023. The market is analyzed based on three segments – product types, end-users, and regions.
The factors such as re-sales of insulin pumps and the increased adoption of advanced technology products are the opportunities for the market players during the forecast period. Increasing awareness among people about diabetes and glucose monitoring devices has a significant impact on the growth of the global insulin pumps market.

Product Analysis:
The market is witnessing an emerging trend for advanced insulin pumps such as Medtronic's MiniMed 530G system. Knowledge about the advantages of insulin pumps systems over traditional injections, meters, and other glucose monitors has led to the market growth in developed countries.
The regulatory scenario is of concern as there has been a wide range of instruments and assays, which range from Class I to Class III devices. Recently, there has been a change in regulations in the European region, which has become a major issue for the market players.

Regional Analysis:
The regions covered in the report are the Americas, EMEA, APAC, and Rest of the World (ROW). The Americas is set to be the leading region for the insulin pumps market growth followed by Europe. Asia Pacific and ROW are set to be the emerging regions. The markets in India, Brazil, and China are expected to grow at a rapid pace during the forecast period as the prevalence of diabetes and lifestyle diseases in these countries is high. These countries are set to be the target regions for the players due to the large untapped market.

Key Players:
The leader in the insulin pumps market is Animas, who is currently occupying the majority of the insulin pumps market share. Medtronic, Roche, Asante, Cellnovo, and Insulet are the other major players in the market. These top players occupy more than half of the market. The report covers the following players:
• Animus Corp.
• Medtronics Inc.
• Insulet Corp.
• Roche Diagnostics
• Cellnovo Ltd.
• Asante
• Nipro Diagnostic Inc.
• Tandem Diabetes Care Inc.
• Sooil Development Co. Ltd.
• Ypsomed

Competitive Analysis:
The tethered pumps segment is dominating the global insulin pumps market, and a lot of new players are focusing on developing technologically advanced reagents and analyzers to gain the market share. The advanced products such as MiniMed 530G system and OmniPod insulin pumps are expected to drive the market growth in the future.
The large players such as F. Hoffmann-La Roche and Medtronics are acquiring companies with products that would complement their existing portfolio. Significant investments in R&D in this market is expected to increase, and collaborations and M&A are expected to continue.

Benefits:
The report provides complete details about the usage and the adoption rate of insulin pumps by various end-users and regions. The key stakeholders use this information to know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the increasing awareness of diseases in the upcoming years along with the details of commercial devices available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report provides complete details about the main business opportunities to the key stakeholders to expand their business and gain revenue in the specific vertical and to analyze before investing or expanding the business in this market.

Key Stakeholders


Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Industry Trends 9
1.3 Pest Analysis 10
2 Report Outline 11
2.1 Report Scope 11
2.2 Report Summary 11
2.3 Research Methodology 12
2.4 Report Assumptions 12
3 Market Snapshot 13
3.1 Total Addressable Market (TAM) 13
3.2 Segmented Addressable Market (SAM) 14
3.3 Related Markets 15
3.3.1 Infusion Pumps Market 15
3.3.2 Diabetes Drugs Market 15
3.3.3 Diabetes Management Market 15
4 Market Outlook 15
4.1 Overview 16
4.2 Market Definition – Infoholic Research 16
4.3 Importance of Insulin Pumps 16
4.4 Market Segmentation 17
4.5 Porter 5(Five) Forces 17
5 Market Characteristics 19
5.1 Evolution 19
5.2 Insulin Pumps Advantages 20
5.3 Insulin Pumps Disadvantages 20
5.4 Role of Insulin Pumps in Healthcare 20
5.5 Market Dynamics 22
5.5.1 Drivers 22
5.5.1.1 Potential increase in the number of aged population 22
5.5.1.2 Growing awareness of insulin pumps in the emerging markets 23
5.5.1.3 Significant focus on diabetes management 23
5.5.1.4 Increasing prevalence of diabetic population 24
5.5.2 Opportunities 24
5.5.2.1 Substitute for conventional diabetes treatments 24
5.5.2.2 Technological advancements 25
5.5.2.3 Significant increase in the number of mergers and acquisitions 26
5.5.2.4 Latest product launches 26
5.5.3 Restraints 27
5.5.3.1 Threat of technological substitutes 27
5.5.3.2 Unfavorable reimbursement plans 28
5.5.3.3 Acute competition in the market 28
5.5.3.4 Issues related to product pricing 29
5.5.4 DRO – Impact Analysis 30
5.5.5 Key Stakeholders 31
6 Types: Market Size and Analysis 32
6.1 Overview 32
6.2 Tethered Pumps 33
6.3 Untethered Pumps 34
6.4 Implantable Pumps 35
7 End User: Market Size and Analysis 37
7.1 Overview 37
7.2 Hospitals 38
7.3 Ambulatory Care 38
7.4 Others 39
8 Regions: Market Size and Analysis 40
8.1 Overview 40
8.2 Americas 41
8.3 EMEA 42
8.4 APAC 43
9 Market Attractiveness 45
9.1 Market Attractiveness by Types 45
9.2 Market Attractiveness by End Users 45
10 Competitive Landscape 47
10.1 Overview 47
11 Vendor Profiles 49
11.1 Animas Corp. 49
11.1.1 Overview 49
11.1.2 Business Focus 52
11.1.3 Business Strategy 52
11.2 Insulet Corp. 53
11.2.1 Overview 53
11.2.2 Business Unit 55
11.2.3 Geographic Presence 56
11.2.4 Business Focus 56
11.2.5 SWOT Analysis 57
11.2.6 Business Strategy 57
11.3 Medtronic Plc 58
11.3.1 Overview 58
11.3.2 Business Unit 68
11.3.3 Geographic Presence 69
11.3.4 Business Focus 69
11.3.5 SWOT Analysis 70
11.3.6 Business Strategy 70
11.4 F.Hoffmann-La Roche Ltd 72
11.4.1 Overview 72
11.4.2 Business Unit 77
11.4.3 Geographic Presence 78
11.4.4 Business Focus 78
11.4.5 SWOT Analysis 79
11.4.6 Business Strategy 79
11.5 Abbott Laboratories 80
11.5.1 Overview 80
11.5.2 Business Unit 84
11.5.3 Geographic Presence 85
11.5.4 Business Focus 85
11.5.5 SWOT Analysis 86
11.5.6 Business Strategy 86
12 Companies to Watch For 87
12.1 Sanofi 87
12.1.1 Overview 87
12.1.2 Sanofi in 2015 88
12.2 B. Braun Melsungen AG 89
12.2.1 Overview 89
12.3 Carestream Health Inc. 90
12.3.1 Overview 90
Annexure 91
12.4 Abbreviations 92

List of Tables

TABLE 1 PREVALENCE OF DIEBETES POPULATION FORECASTING BY REGION 8
TABLE 2 INSULIN PUMPS PRICING 16
TABLE 3 DIABETES PREVALENCE AND FORECASTING 23
TABLE 4 RECENT MERGERS AND ACQUISITIONS 26
TABLE 5 RECENT PRODUCT LAUNCHES 26
TABLE 6 AVERAGE PRICE OF REFURBISHED MAMMOGRAMS 29
TABLE 7 GLOBAL INSULIN PUMPS MARKET BY TYPES, 2016–2023 ($MILLION) 33
TABLE 8 GLOBAL INSULIN PUMPS MARKET BY END-USER SEGMENTATION, 2016–2023 ($MILLION) 38
TABLE 9 GLOBAL INSULIN PUMPS MARKET REVENUE BY REGIONS, 2016–2023 ($MILLION) 40
TABLE 10 GLOBAL INSULIN PUMPS MARKET BY VENDOR RANKING, 2016 47
TABLE 11 ANIMAS CORP.: RECENT DEVELOPMENTS 49
TABLE 12 INSULET CORP.: RECENT DEVELOPMENTS 53
TABLE 13 MEDTRONIC PLC: OFFERINGS 58
TABLE 14 MEDTRONIC PLC: RECENT DEVELOPMENTS 60
TABLE 15 F. HOFFMANN-LA ROCHE: OFFERINGS 72
TABLE 16 F. HOFFMANN-LA ROCHE.: RECENT DEVELOPMENTS 72
TABLE 17 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 80
TABLE 18 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 81
TABLE 19 SANOFI: SNAPSHOT 87
TABLE 20 SANOFI: RECENT DEVELOPMENTS 87
TABLE 21 B. BRAUN MELSUNGEN AG: SNAPSHOT 89
TABLE 22 TOSHIBA MEDICAL SYSTEMS CORP.: RECENT DEVELOPMENTS 89
TABLE 23 CARESTREAM HEALTH INC.: RECENT DEVELOPMENTS 91


List of  Charts


CHART 1 PEST ANALYSIS OF GLOBAL INSULIN PUMPS MARKET 10
CHART 2 RESEARCH METHODOLOGY OF GLOBAL INSULIN PUMPS MARKET 12
CHART 3 DIABETES CARE DEVICES MARKET SEGMENTATION 13
CHART 4 GLOBAL INSULIN PUMPS MARKET REVENUE FORECAST, 2016–2023 ($MILLION) 14
CHART 5 INSULIN PUMPS PROCEDURE 16
CHART 6 GLOBAL INSULIN PUMPS MARKET BY SEGMENTATION 17
CHART 7 PORTER 5 FORCES ON GLOBAL INSULIN PUMPS MARKET 17
CHART 8 INSULIN PUMPS FEATURES 20
CHART 9 DRO – IMPACT ANALYSIS OF GLOBAL INSULIN PUMPS MARKET 30
CHART 10 KEY STAKEHOLDERS 31
CHART 11 GLOBAL INSULIN PUMPS MARKET BY TYPE SEGMENTATION, 2016 (%) 32
CHART 12 GLOBAL INSULIN PUMPS MARKET BY END-USER SEGMENTATION, 2023 (%) 33
CHART 13 GLOBAL TETHERED INSULIN PUMPS MARKET REVENUE FORECAST, 2017–2023 ($MILLION) 34
CHART 14 GLOBAL UNTETHERED INSULIN PUMPS MARKET REVENUE FORECAST, 2017–2023 ($MILLION) 35
CHART 15 GLOBAL IMPLANTABLE INSULIN PUMPS MARKET REVENUE FORECAST, 2017–2023 ($MILLION) 36
CHART 16 GLOBAL INSULIN PUMPS MARKET BY END-USER SEGMENTATION, 2016 (%) 37
CHART 17 GLOBAL INSULIN PUMPS MARKET BY END-USER SEGMENTATION, 2023 (%) 37
CHART 18 GLOBAL MAMMOGRAPHY MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%) 40
CHART 19 GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHICAL SEGMENTATION, 2023(%) 40
CHART 20 INSULIN PUMPS MARKET REVENUE IN THE AMERICAS, 2016–2023 ($MILLION) 41
CHART 21 MAMMOGRAPHY MARKET REVENUE IN THE EMEA REGION, 2016–2023 ($MILLION) 42
CHART 22 MAMMOGRAPHY MARKET REVENUE IN THE APAC REGION, 2016–2023 ($MILLION) 43
CHART 23 MARKET ATTRACTIVENESS BY TYPES 45
CHART 24 MARKET ATTRACTIVENESS BY TYPES 46
CHART 25 INSULET CORP.: OVERVIEW SNAPSHOT 54
CHART 26 INSULET CORP.: BUSINESS UNITS 55
CHART 27 INSULET CORP.: GEOGRAPHIC PRESENCE 56
CHART 28 INSULET CORP.: SWOT ANALYSIS 57
CHART 29 MEDTRONIC PLC: OVERVIEW SNAPSHOT 67
CHART 30 MEDTRONIC PLC: BUSINESS UNITS 68
CHART 31 MEDTRONIC PLC: GEOGRAPHICAL PRESENCE 69
CHART 32 MEDTRONIC PLC: SWOT ANALYSIS 70
CHART 33 F. HOFFMANN-LA ROCHE: OVERVIEW SNAPSHOT 76
CHART 34 F. HOFFMANN.LA ROCHE.: BUSINESS UNITS 77
CHART 35 F. HOFFMANN-LA ROCHE GEOGRAPHICAL PRESENCE 78
CHART 36 F. HOFFMANN-LA ROCHE: SWOT ANALYSIS 79
CHART 37 ABBOTT LABORATORIES.: OVERVIEW SNAPSHOT 83
CHART 38 ABBOTT LABORATORIES.: BUSINESS UNITS 84
CHART 39 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 85
CHART 40 ABBOTT LABORATORIES.: SWOT ANALYSIS 86

Worldwide Insulin Pumps Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017–2023
Overview:
Insulin pump is a small and discreet device that delivers a specific amount of insulin through a needle inserted underneath the skin. The insulin pump is integrated with the receiver, transmitter, and a sensor that can be programmed to deliver constant doses of insulin during the day. It delivers and regulates blood sugar level in the body. It consists of a disposable infusion set, a cannula for subcutaneous insertion, a tubing system to connect the cannula with the insulin reservoir, and a disposable reservoir for insulin set.

Factors such as rising prevalence of diabetic patients, technological advancements, and the increasing potential in the emerging countries are expected to drive the market growth during the forecast period. The high cost of insulin pumps and stringent regulatory approval process are factors hampering the market growth.
The markets in India, Brazil, and China are also expected to grow at a rapid pace during the forecast period due to the high prevalence of diabetes in these countries.

Market Analysis:
The global insulin pumps market is estimated to witness a CAGR of 8.3% during the forecast period 2017–2023. The market is analyzed based on three segments – product types, end-users, and regions.
The factors such as re-sales of insulin pumps and the increased adoption of advanced technology products are the opportunities for the market players during the forecast period. Increasing awareness among people about diabetes and glucose monitoring devices has a significant impact on the growth of the global insulin pumps market.

Product Analysis:
The market is witnessing an emerging trend for advanced insulin pumps such as Medtronic's MiniMed 530G system. Knowledge about the advantages of insulin pumps systems over traditional injections, meters, and other glucose monitors has led to the market growth in developed countries.
The regulatory scenario is of concern as there has been a wide range of instruments and assays, which range from Class I to Class III devices. Recently, there has been a change in regulations in the European region, which has become a major issue for the market players.

Regional Analysis:
The regions covered in the report are the Americas, EMEA, APAC, and Rest of the World (ROW). The Americas is set to be the leading region for the insulin pumps market growth followed by Europe. Asia Pacific and ROW are set to be the emerging regions. The markets in India, Brazil, and China are expected to grow at a rapid pace during the forecast period as the prevalence of diabetes and lifestyle diseases in these countries is high. These countries are set to be the target regions for the players due to the large untapped market.

Key Players:
The leader in the insulin pumps market is Animas, who is currently occupying the majority of the insulin pumps market share. Medtronic, Roche, Asante, Cellnovo, and Insulet are the other major players in the market. These top players occupy more than half of the market. The report covers the following players:
• Animus Corp.
• Medtronics Inc.
• Insulet Corp.
• Roche Diagnostics
• Cellnovo Ltd.
• Asante
• Nipro Diagnostic Inc.
• Tandem Diabetes Care Inc.
• Sooil Development Co. Ltd.
• Ypsomed

Competitive Analysis:
The tethered pumps segment is dominating the global insulin pumps market, and a lot of new players are focusing on developing technologically advanced reagents and analyzers to gain the market share. The advanced products such as MiniMed 530G system and OmniPod insulin pumps are expected to drive the market growth in the future.
The large players such as F. Hoffmann-La Roche and Medtronics are acquiring companies with products that would complement their existing portfolio. Significant investments in R&D in this market is expected to increase, and collaborations and M&A are expected to continue.

Benefits:
The report provides complete details about the usage and the adoption rate of insulin pumps by various end-users and regions. The key stakeholders use this information to know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the increasing awareness of diseases in the upcoming years along with the details of commercial devices available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report provides complete details about the main business opportunities to the key stakeholders to expand their business and gain revenue in the specific vertical and to analyze before investing or expanding the business in this market.

Key Stakeholders


Read More

Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Industry Trends 9
1.3 Pest Analysis 10
2 Report Outline 11
2.1 Report Scope 11
2.2 Report Summary 11
2.3 Research Methodology 12
2.4 Report Assumptions 12
3 Market Snapshot 13
3.1 Total Addressable Market (TAM) 13
3.2 Segmented Addressable Market (SAM) 14
3.3 Related Markets 15
3.3.1 Infusion Pumps Market 15
3.3.2 Diabetes Drugs Market 15
3.3.3 Diabetes Management Market 15
4 Market Outlook 15
4.1 Overview 16
4.2 Market Definition – Infoholic Research 16
4.3 Importance of Insulin Pumps 16
4.4 Market Segmentation 17
4.5 Porter 5(Five) Forces 17
5 Market Characteristics 19
5.1 Evolution 19
5.2 Insulin Pumps Advantages 20
5.3 Insulin Pumps Disadvantages 20
5.4 Role of Insulin Pumps in Healthcare 20
5.5 Market Dynamics 22
5.5.1 Drivers 22
5.5.1.1 Potential increase in the number of aged population 22
5.5.1.2 Growing awareness of insulin pumps in the emerging markets 23
5.5.1.3 Significant focus on diabetes management 23
5.5.1.4 Increasing prevalence of diabetic population 24
5.5.2 Opportunities 24
5.5.2.1 Substitute for conventional diabetes treatments 24
5.5.2.2 Technological advancements 25
5.5.2.3 Significant increase in the number of mergers and acquisitions 26
5.5.2.4 Latest product launches 26
5.5.3 Restraints 27
5.5.3.1 Threat of technological substitutes 27
5.5.3.2 Unfavorable reimbursement plans 28
5.5.3.3 Acute competition in the market 28
5.5.3.4 Issues related to product pricing 29
5.5.4 DRO – Impact Analysis 30
5.5.5 Key Stakeholders 31
6 Types: Market Size and Analysis 32
6.1 Overview 32
6.2 Tethered Pumps 33
6.3 Untethered Pumps 34
6.4 Implantable Pumps 35
7 End User: Market Size and Analysis 37
7.1 Overview 37
7.2 Hospitals 38
7.3 Ambulatory Care 38
7.4 Others 39
8 Regions: Market Size and Analysis 40
8.1 Overview 40
8.2 Americas 41
8.3 EMEA 42
8.4 APAC 43
9 Market Attractiveness 45
9.1 Market Attractiveness by Types 45
9.2 Market Attractiveness by End Users 45
10 Competitive Landscape 47
10.1 Overview 47
11 Vendor Profiles 49
11.1 Animas Corp. 49
11.1.1 Overview 49
11.1.2 Business Focus 52
11.1.3 Business Strategy 52
11.2 Insulet Corp. 53
11.2.1 Overview 53
11.2.2 Business Unit 55
11.2.3 Geographic Presence 56
11.2.4 Business Focus 56
11.2.5 SWOT Analysis 57
11.2.6 Business Strategy 57
11.3 Medtronic Plc 58
11.3.1 Overview 58
11.3.2 Business Unit 68
11.3.3 Geographic Presence 69
11.3.4 Business Focus 69
11.3.5 SWOT Analysis 70
11.3.6 Business Strategy 70
11.4 F.Hoffmann-La Roche Ltd 72
11.4.1 Overview 72
11.4.2 Business Unit 77
11.4.3 Geographic Presence 78
11.4.4 Business Focus 78
11.4.5 SWOT Analysis 79
11.4.6 Business Strategy 79
11.5 Abbott Laboratories 80
11.5.1 Overview 80
11.5.2 Business Unit 84
11.5.3 Geographic Presence 85
11.5.4 Business Focus 85
11.5.5 SWOT Analysis 86
11.5.6 Business Strategy 86
12 Companies to Watch For 87
12.1 Sanofi 87
12.1.1 Overview 87
12.1.2 Sanofi in 2015 88
12.2 B. Braun Melsungen AG 89
12.2.1 Overview 89
12.3 Carestream Health Inc. 90
12.3.1 Overview 90
Annexure 91
12.4 Abbreviations 92

Read More

List of Tables

TABLE 1 PREVALENCE OF DIEBETES POPULATION FORECASTING BY REGION 8
TABLE 2 INSULIN PUMPS PRICING 16
TABLE 3 DIABETES PREVALENCE AND FORECASTING 23
TABLE 4 RECENT MERGERS AND ACQUISITIONS 26
TABLE 5 RECENT PRODUCT LAUNCHES 26
TABLE 6 AVERAGE PRICE OF REFURBISHED MAMMOGRAMS 29
TABLE 7 GLOBAL INSULIN PUMPS MARKET BY TYPES, 2016–2023 ($MILLION) 33
TABLE 8 GLOBAL INSULIN PUMPS MARKET BY END-USER SEGMENTATION, 2016–2023 ($MILLION) 38
TABLE 9 GLOBAL INSULIN PUMPS MARKET REVENUE BY REGIONS, 2016–2023 ($MILLION) 40
TABLE 10 GLOBAL INSULIN PUMPS MARKET BY VENDOR RANKING, 2016 47
TABLE 11 ANIMAS CORP.: RECENT DEVELOPMENTS 49
TABLE 12 INSULET CORP.: RECENT DEVELOPMENTS 53
TABLE 13 MEDTRONIC PLC: OFFERINGS 58
TABLE 14 MEDTRONIC PLC: RECENT DEVELOPMENTS 60
TABLE 15 F. HOFFMANN-LA ROCHE: OFFERINGS 72
TABLE 16 F. HOFFMANN-LA ROCHE.: RECENT DEVELOPMENTS 72
TABLE 17 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 80
TABLE 18 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 81
TABLE 19 SANOFI: SNAPSHOT 87
TABLE 20 SANOFI: RECENT DEVELOPMENTS 87
TABLE 21 B. BRAUN MELSUNGEN AG: SNAPSHOT 89
TABLE 22 TOSHIBA MEDICAL SYSTEMS CORP.: RECENT DEVELOPMENTS 89
TABLE 23 CARESTREAM HEALTH INC.: RECENT DEVELOPMENTS 91


List of  Charts


CHART 1 PEST ANALYSIS OF GLOBAL INSULIN PUMPS MARKET 10
CHART 2 RESEARCH METHODOLOGY OF GLOBAL INSULIN PUMPS MARKET 12
CHART 3 DIABETES CARE DEVICES MARKET SEGMENTATION 13
CHART 4 GLOBAL INSULIN PUMPS MARKET REVENUE FORECAST, 2016–2023 ($MILLION) 14
CHART 5 INSULIN PUMPS PROCEDURE 16
CHART 6 GLOBAL INSULIN PUMPS MARKET BY SEGMENTATION 17
CHART 7 PORTER 5 FORCES ON GLOBAL INSULIN PUMPS MARKET 17
CHART 8 INSULIN PUMPS FEATURES 20
CHART 9 DRO – IMPACT ANALYSIS OF GLOBAL INSULIN PUMPS MARKET 30
CHART 10 KEY STAKEHOLDERS 31
CHART 11 GLOBAL INSULIN PUMPS MARKET BY TYPE SEGMENTATION, 2016 (%) 32
CHART 12 GLOBAL INSULIN PUMPS MARKET BY END-USER SEGMENTATION, 2023 (%) 33
CHART 13 GLOBAL TETHERED INSULIN PUMPS MARKET REVENUE FORECAST, 2017–2023 ($MILLION) 34
CHART 14 GLOBAL UNTETHERED INSULIN PUMPS MARKET REVENUE FORECAST, 2017–2023 ($MILLION) 35
CHART 15 GLOBAL IMPLANTABLE INSULIN PUMPS MARKET REVENUE FORECAST, 2017–2023 ($MILLION) 36
CHART 16 GLOBAL INSULIN PUMPS MARKET BY END-USER SEGMENTATION, 2016 (%) 37
CHART 17 GLOBAL INSULIN PUMPS MARKET BY END-USER SEGMENTATION, 2023 (%) 37
CHART 18 GLOBAL MAMMOGRAPHY MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%) 40
CHART 19 GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHICAL SEGMENTATION, 2023(%) 40
CHART 20 INSULIN PUMPS MARKET REVENUE IN THE AMERICAS, 2016–2023 ($MILLION) 41
CHART 21 MAMMOGRAPHY MARKET REVENUE IN THE EMEA REGION, 2016–2023 ($MILLION) 42
CHART 22 MAMMOGRAPHY MARKET REVENUE IN THE APAC REGION, 2016–2023 ($MILLION) 43
CHART 23 MARKET ATTRACTIVENESS BY TYPES 45
CHART 24 MARKET ATTRACTIVENESS BY TYPES 46
CHART 25 INSULET CORP.: OVERVIEW SNAPSHOT 54
CHART 26 INSULET CORP.: BUSINESS UNITS 55
CHART 27 INSULET CORP.: GEOGRAPHIC PRESENCE 56
CHART 28 INSULET CORP.: SWOT ANALYSIS 57
CHART 29 MEDTRONIC PLC: OVERVIEW SNAPSHOT 67
CHART 30 MEDTRONIC PLC: BUSINESS UNITS 68
CHART 31 MEDTRONIC PLC: GEOGRAPHICAL PRESENCE 69
CHART 32 MEDTRONIC PLC: SWOT ANALYSIS 70
CHART 33 F. HOFFMANN-LA ROCHE: OVERVIEW SNAPSHOT 76
CHART 34 F. HOFFMANN.LA ROCHE.: BUSINESS UNITS 77
CHART 35 F. HOFFMANN-LA ROCHE GEOGRAPHICAL PRESENCE 78
CHART 36 F. HOFFMANN-LA ROCHE: SWOT ANALYSIS 79
CHART 37 ABBOTT LABORATORIES.: OVERVIEW SNAPSHOT 83
CHART 38 ABBOTT LABORATORIES.: BUSINESS UNITS 84
CHART 39 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 85
CHART 40 ABBOTT LABORATORIES.: SWOT ANALYSIS 86

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$2750
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$3500
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$4500
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global Diabetic Foot Ulcer Treatment Market Size Status and Forecast 2021 2027
Global Diabetic Foot Ulcer Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-25O4196
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Insulin Infusion Pumps Market Research Report 2021
Global Insulin Infusion Pumps Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-3M4699
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Blood Glucose Testing Devices Market Research Report 2021
Global Blood Glucose Testing Devices Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-13Q4387
Mon Feb 01 00:00:00 UTC 2021

Add to Cart

Global Continuous Blood Glucose Monitoring Market Research Report 2021
Global Continuous Blood Glucose Monitoring Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-31L4092
Mon Feb 01 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0